Extracellular Vesicles in Periodontal Medicine : The Candidates Linking Oral Health to General Health by Yoshida, Kaya et al.
Journal of Oral Health and Biosciences　33（１）：15～ 23，2020
Extracellular Vesicles in Periodontal Medicine: 
The Candidates Linking Oral Health to General Health
Kaya YOSHIDA1）, Kayo YOSHIDA2）, Mariko SEYAMA2）, 
Kazumi OZAKI2）, Hirohiko OKAMURA3）
Keywords：periodontal diseases, systemic diseases, extracellular vesicles
Abstract：The term, periodontal medicine is used to describe the multitude of systemic diseases 
which are regarded to link periodontal disease. The concept of periodontal medicine has been widely 
accepted today, however, the molecular mechanisms which periodontal diseases impact general health 
in whole body are not elucidated in detail. Extracellular vesicles (EVs) and outer membrane vesicles 
(OMVs) are the nano-sized particles released from mammalian cells and bacterial cells resectively, 
which influence the health and various disease by transporting biological factors to the neighbor and 
distant cells. In this review, we will discuss whether EVs and OMVs produced in periodontal diseases 
could be implicated in periodontal medicine.
1. Introduction
　The links between periodontal diseases and various 
systemic diseases, including diabetes mellitus, cardiovascular 
diseases, rheumatoid arthritis and chronic obstructive 
pulmonary disease, have been well accepted today1-4). 
“Periodontal medicine” is a general term for these systemic 
diseases, and is used to describe how periodontal condition 
impact extraoral and systemic health5). It has been suggested 
that the induction of inflammatory cytokines and immune 
responses by oral bacterial infection in periodontal tissue 
may be risk factors for periodontal medicine6). However, the 
molecular mechanisms how these factors in the oral cavity 
can reach to the distant organs, and how these factors impact 
general health in whole body are not elucidated in detail. 
　Extracellular vesicles (EVs) are the nano-sized particles 
released from cells,  which regulate cell-to-cell and 
intracellular communications by transporting their cargoes to 
the neighbor and distant cells. EVs derived from pathogenic 
bacteria, as known as outer membrane vesicles (OMVs), 
are also affect the host immune systems and disease 
development7-9). Moreover, EVs derived from host cells 
infected with pathogenic bacteria have been reported to induce 
diseases in the distant organs10, 11). 
　In chronic periodontitis region, the abundant of EVs appear 
to be produced by various types of cells, including cells that 
form periodontal tissue, periodontal bacteria and periodontal 
bacteria-infected host cells (Fig.1). The released EVs into 
extracellular environment, then, might be implicated in 
periodontal health and diseases. The part of released EVs are 
likely to be taken up into body fluids such as saliva and blood, 
and then be delivered to the distant organs, and there affect 
systemic health. We, therefore, hypothesized that EVs may 
be the candidates which connect the oral cavity to the whole 
body, and play important roles in pathogenesis of periodontal 
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medicine. 
　In this review, we aim to discuss whether EVs produced in 
periodontal diseases could be strong candidates for regulator 
of periodontal medicine. We will first explain the general 
properties of EVs, then introduce the current insights about 
the role of EVs in periodontal diseases, as well as periodontal 
medicine. Finally, we will propose the required further 
research in the fields of EVs.
2. Properties of extracellular vesicles
2.1. EVs from mammalian cells
　EVs are the general term of membrane-enclosed vesicles 
that are released from various mammalian cell types to 
body fluids in normal physiology and abnormalities. EVs 
are divided into two categories, ectosomes and exosomes 
according to their size and origins12). Ectosomes including 
microvesicles, microparticles and large vesicles, are vesicles 
generated by budding of plasma membrane and in the size 
range of 50 nm to 1 μm in diameter. Exosomes are generated 
by exocytosis of intracellular multivesicular bodies such as 
endosomes, and have a size range of 40 to 160 nm in diameter. 
　EVs include many kinds of cellular constituents as called as 
“cargoes” , for example, nucleic acids (e.g., double-stranded 
DNA, single-stranded DNA, mRNA, micro RNA (miRNA)), 
proteins (e.g., cytosolic proteins, nuclear proteins and cell-
surface proteins), lipids and metabolites13-15). Because EVs 
are made from cellular lipid bilayers, EVs can deliver their 
cargoes into recipient cells through body fluids excepting 
degradation and immune clearance, leading to effective 
alteration of biological responses in health and disease. 
Indeed, EVs miRNA are delivered to recipient cells and 
suppress the expression of target genes16). The membrane-
associated receptor proteins in EVs are transferred to recipient 
cells, lead to activation of signaling pathways17).
　Accumulating evidence has revealed the contribution of 
EVs to health and various disease such as immune responses, 
pregnancy, cancer progression, metabolic and cardiovascular 
diseases. For example, breast milk-derived EVs enhance the 
number of T-regulatory cells, suggesting that EVs can regulate 
postnatal health and immune tolerance18). In obese mice fed a 
high fat diet, EVs miRNAs promote insulin resistance through 
downregulation of Ppara (peroxisome proliferator-activated 
receptor alpha) in white adipose tissue19). The reports showing 
that heat shock proteins in EVs promote survival of metastatic 
oral cancer cells20), and that noncoding RNA in EVs can 
increase growth and spread of hepatocellular cancers21) 
provide the potential of EVs as cancer diagnostic tools. 
2.2. OMVs from bacteria
　Like mammalian cells, prokaryotic microorganisms such as 
gram-positive bacteria, gram-negative bacteria, mycobacteria 
and fungi can produce and release EVs into extracellular 
Fig. 1 Extracellular vesicles (EVs) observed in region of periodontal diseases
In chronic periodontitis region, EVs appear to be produced by various types of cells as follows: i) EVs derived from cells 
that form periodontal tissue, ii) OMVs of periodontal bacteria and iii) EVs derived from periodontal bacteria-infected host 
cells. The released EVs into extracellular environment, then, are implicated in periodontal health and diseases. The part 
of released EVs are possible to be taken up into body fluids, and then be delivered to the distant organs, and there affect 
systemic health.
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environment22-24). EVs produced by microorganisms are 
often called as outer membrane vesicles (OMVs), therefore, 
the term “OMVs” will be used to refer bacterial EVs in this 
review. The studies about OMVs from gram-negative bacteria 
have been progressed since they were first observed in the 
1960s, but there was little known about OMVs from gram-
positive bacteria, mycobacteria or fungi. Some reviews on 
OMVs from gram-positive bacteria are available24, 25), then, we 
will focus on gram-negative bacterial OMVs in this section. 
　The gram-negative cell envelope consists of two membrane 
(e.g., outer membrane and cytoplasmic membrane) and 
periplasmic space which in between them26). The cytoplasmic 
membrane is typical phospholipid bilayer, while the outer 
membrane is composed of interior leaflet of phospholipids 
and exterior leaflet of lipopolysaccharide (LPS). In outer 
membrane, there are many kinds of integral outer membrane 
proteins and lipid-anchored lipoproteins. The periplasmic 
space is consists with the net-like peptidoglycan (PG) layer 
and periplasmic proteins. 
　OMVs released from various gram-negative bacteria are 
spherical blebs in a diameter of 20 to 200 nm which are 
derived from bacterial envelope27). It has been regarded that 
OMVs are generated by “vesiculation” occured by the loss of 
interaction between outer membrane and the underlying PG 
layer without cell lysis25). On the other hand, OMVs could be 
generated by the turgor pressure of outer membrane caused 
by the accumulation of periplasmic proteins and PG fragment 
in periplasmic space28). Recently, it was also observed that 
explosive cell lysis produces OMVs through the vesiculation 
of shattered membrane fragments29). 
　Gram-negative bacterial OMVs have reported to include 
LPS, lipids, proteins, nucleic acids, and virulence factors. 
Because OMVs originate from bacterial envelope, it seems 
to be reasonable that the components of outer membrane 
such as particular lipid species, LPS and outer membrane 
proteins (Omps) and lipid-anchored proteins are enriched in 
OMVs30-32). In most case, inner-membrane and cytoplasmic 
components were also detected in OMVs33, 34).  High-
throughput proteomic analysis have identified more than 100 
vesicle proteins in OMVs derived from various kinds of Gram-
negative bacteria25). Two types of vesicular DNAs (luminal 
and surface-associated DNA) and RNA were identified in EVs 
derived from E. coli and Neisseria gonorrhoeae35, 36), however, 
the mechanisms how specific DNA/RNA are sorted into EVs 
remain unclear. 
　Importantly, OMVs can play physical and pathological 
roles in bacteria-bacteria (quorum sensing, biofilm formation, 
bacterial survival and antibiotic resistance) and bacteria-host 
interactions (virulence factor delivery, host cell modulation 
and immune evasion) by directly activation or by delivering 
cargoes to the recipient cells. The reviews on the functions 
of general bacterial OMVs were available25, 37), then, we 
will focus on OMVs derived from periodontal bacteria and 
overview its functions in the next section. 
3. The roles of EVs/OMVs in periodontal diseases 
and periodontal medicine
　It is possible that both cellular EVs and bacterial OMVs 
are released into the region of chronic periodontitis (Fig. 1). 
In this section, we will discuss about the involvement of these 
EVs/OMVs in etiology of periodontal diseases as well as 
periodontal medicine. 
3.1. EVs in periodontal diseases
　Some reports have revealed that EVs derived from cells 
in periodontal tissue might be implicated in pathology and 
progression of periodontal diseases. The protein-enriched EVs 
derived from keratinocytes were transferred to fibroblasts, 
and there increase fibroblast migration by regulating gene 
and protein expression, suggesting that keratinocytes EVs 
can modulate wound healing38). Gingival epithelial cells 
(GECs) also produce EVs under infection with or without 
oral bacterium biofilm. Interestingly, the infection with oral 
bacteria biofilms increased EVs production, whereas the 80% 
of identified cargo proteins in EVs were common between 
control and biofilm-treated GECs. EVs derived from control 
and biofilm-treated GECs increase expression of genes 
associated with inflammation and matrix degradation39). These 
observation suggested that EVs derived from dental pocket 
epithelium affect the progression of periodontal diseases by 
modulating gene expression in the underlying fibroblasts to 
control inflammation.
　The human periodontal ligament fibroblast (hPDLFs) 
were also observed to produce EVs which affect osteogenic 
activity40). EVs isolated from cultured media of hPDLFs 
were rich in CD9, CD63 and TSG101 proteins, and treatment 
with P. gingivalis LPS significantly increase the protein 
concentration in EVs. EVs of P. gingivalis LPS-treated 
hPDLFs were incorporated into human osteoblast cell line 
MG-63, and there inhibited osteoblastogenesis by decreasing 
expression of bone-related genes such as alkaline phosphatase 
(ALP), type I collagen and runt-related transcription factor-2 
(Runx2). In addition, many kinds of miRNA included in 
EVs were associated with alveolar bone loss in periodontal 
diseases41), suggesting that localized periodontal infection and 
inflammation may influence bone remodeling by release of 
EVs.
　Indeed, EVs isolated from human saliva were observed to 
include protein cargoes and influence biological responses. 
The levels of CD9 and CD81-positive EVs isolated from 
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human saliva were decreased in patients with periodontitis 
compared with healthy controls42). CD9 and CD81, known as 
general marker for EVs, are tetraspanins which interact with 
transmembrane molecules, including integrins and receptors, 
and affect biological responses by organization of molecules 
in tetraspanin-enriched microdomain43). The dysfunction of 
these proteins resulted in induction of systemic inflammation 
and delayed wound healing44, 45). These reports proposed that 
the alteration of CD9 and CD81-including EVs in saliva may 
play important roles in progression of periodontal diseases. 
3.2. EVs in periodontal medicine
　As mentioned above, it has been widely accepted that 
EVs are associated with various kinds of systemic diseases, 
therefore, the cargoes of EVs isolated from peripheral blood 
(e.g. microRNA and proteins) are used as biomarker and 
diagnostic tools. EVs are also detected in saliva, and the 
correlation between salivary EVs and systemic diseases has 
been reported46). Based on these observations, it is possible 
that EVs might be produced in periodontal region and then 
released into saliva or blood circulation, and impact systemic 
diseases. However, there is little evidence indicating that EVs 
produced by inflammation or infection during periodontitis 
can directly influence systemic diseases.
　On the other hand, some bacteria, but not periodontal 
bacteria, can modulate systemic diseases in the distant organs 
by delivering their own virulence factors packaged in the 
host cell EVs. Like the infection with periodontal bacteria, 
Helicobacter pylori (H. pylori), a gram-negative bacteria 
colonize in the epithelium of stomach and cause gastric 
inflammation and cancer, could also contribute to various 
extragastrointestinal diseases such as cardiovascular diseases, 
Alzheimer's diseases and diabetes mellitus47). Indeed, EVs 
isolated from H. pylori-infected host cells contain abundant 
of cytotoxin-associated gene A (CagA) proteins, a major H. 
pylori virulence factor48). These EVs-packaged CagA can be 
taken-up into blood circulation and delivered to the distant 
organs, and influence extra-gastric diseases49, 50). It is worth 
investigating whether EVs from periodontal bacterial-infected 
cells could have similar mechanisms in the development of 
extra-oral diseases. 
3.3. OMVs in periodontal diseases
　Like other bacteria, periodontopathic bacteria, including 
Porphyromonas gingivalis (Pg), Fusobacterium nucleatum 
(Fn) and Aggregatibacter actinomycetemcomitans (Aa), 
are able to produce OMVs (Fig. 2). Analysis using liquid 
chromatograpy-tandem mass spectrometry (LC-MS/MS) 
revealed that these OMVs contained numerous putative 
virulence-related proteins51-53). 
　Among periodontal bacterial OMVs, Pg OMVs are well-
known to impact periodontal diseases by regulating the 
environment of bacteria such as bacterial plaque formation, 
aggregation and attachment. Pg OMVs have capable to 
facilitate the aggregation of nonaggregating species such 
as Treponema denticola,  Eubacteium saburreum and 
Capnocytophaga ochracea54). Pg OMVs enhance the invasion 
of Tannerella forsythiainto epithelial cells55).
　Pg OMVs were also reported to affect the host cell 
functions. Because Pg OMVs are enriched in gingipains. the 
cysteine proreases regarded as Pg major virulence compared 
to Pg bacterial surface, they allows Pg to spread throughout 
periodontal tissue and invade into the host cells53, 56). 
Moreover, OMV-bound gingipains are more stable to heat if 
compared to soluble gingipains57), suggesting that stabilization 
of gingipains by packaging OMVs may be helpful for Pg to 
survive in periodontal pockets and to progress periodontal 
disease.
　Pg OMVs themselves are also considered to be internalized 
by gingival epithelial and endothelial cells via caveolin-
Fig. 2 Outer membrane vesicles (OMVs) of periodontal bacteria
The images of OMVs through scanning electron microscopy (SEM) (A) or transmission electron microscopy (TEM) (B, C). 
(A) Cultured Pg observed through SEM. The arrows indicate OMVs derived from bacterial cells. The bars indicate 1000 
nm. (B), (C) The shape of OMVs isolated from the Pg and Fn culture media, respectively (×20,000).
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dependent or lipid raft-mediated endocytosis, and cause the 
destruction of gingival tissue58). For example, Pg OMVs 
within host cells can cause functional impairment of cellular 
migration and detachment in epithelial cells59, 60). Pg OMVs 
also inhibited wound repair by attenuating the proliferation 
and of fibroblasts and endothelial cells61).
　Moreover, many studies revealed that Pg OMVs can 
promote inflammatory cytokines through by pattern 
recognition receptors (PPPs) in gingival epithelial cells, 
fibroblasts, endotherial cells and macrophages62). The 
proinflammatory cytokines are considered to activate the 
neutrophils, T and B lymphocytes, macrophages, natural killer 
cells and osteoclasts, resulting in the destruction of connective 
tissue and alveolar bone in chronic periodontitis.
3.4. OMVs in periodontal medicine
　In contrast, the roles of OMVs derived from periodontal 
bacteria on systemic diseases has been less understood. 
A study indicated that Pg OMVs were reported to induce 
the calcification of vascular smooth muscle cells and 
mouse aortas by promoting the activity of key osteogenic 
transcription factor, runt-related transcription factor 2 (Runx2) 
via ERK signaling63). This observation may suggested that 
OMVs derived from periodontal bacteria are involved in the 
pathogenesis of atherosclerosis. 
　In addition, the relationship between citrullinated proteins 
and periodontal medicines has been noticed. Pg is the 
only human pathogen expressing the citrullinated proteins 
by peptidyl arginine deiminase (PAD), which catalyzes 
modification of peptidyl-arginine to peptidyl-citrulline 
with ammonia. PAD were proposed to link periodontal 
diseases and systemic diseases such as rheumatoid arthritis, 
atherosclerosis and Alzheimer's diseases64). Indeed, a recent 
study demonstrated that 51 citrullinated proteins were 
identified in Pg OMVs65). These important findings proposed 
that citrullinated surface proteins in Pg OMVs could link 
periodontal diseases to systemic diseases. 
　Notably, we have recently reported that Pg OMV alteres 
glucose metabolisms in the liver and contributes to the 
progression of diabetes mellitus66). In agreement with other 
studies, we also identified various Pg virulence factors 
such as gingipains (Kgp, RgpA, RgpB) and components of 
fimbriae (FimA, MFAs) in Pg OMVs by LC-MS/MS analysis. 
The intraperitoneal injection of Pg OMVs attenuated insulin 
sensitivity in the liver cells, leading to the suppression of 
hepatic glycogen synthesis in mice. This attenuation of the 
glycogen synthesis actually increased blood glucose level in 
Pg OMV-treated mice. In addition, Pg OMVs also attenuated 
the insulin-induced Akt/ glycogen synthase kinase-3β 
(GSK-3β) signaling in hepatic HepG2 cells. Importantly, 
the analyze by IVIS spectrum imaging system indicated that 
Pg OMVs which were injected into abdominal cavity or tail 
vein can transfer and accumulate in the liver through blood 
circulation in vivo. This means that the delivery of bacterial 
virulence by OMVs might be important mechanism which 
induce periodontal medicines. 
　Consistent with our result, Han EC et al. also indicated 
that OMVs derived from periodontal bacteria can influence 
systemic diseases by delivering their cargoes to the distant 
organs in vivo67). They purified OMVs from gram-negative 
periodontal bacteria, Aggregatibactor actinomycetemcomitans 
(Aa), and treated human macrophage cell line U937 with Aa 
OMVs. Aa OMVs contained miRNA and deliver them to host 
U937 macrophages, and there, induced TNF-α expression 
through TLR-8 and NF-κB signaling. Interestingly, the cardiac 
injection of Aa OMVs were successfully delivered to the brain 
after crossing the blood-brain barrier. These miRNA cargoes 
in Aa OMVs actually promoted TNF-α expression in the 
mouse brain, suggesting that miRNA in Aa OMVs regulated 
host gene expression. It was also proposed that the transfer of 
periodontal bacterial miRNA by OMVs to the brain may cause 
neuroinflammatory diseases likes Alzheimer's.
4. Conclusion 
　Due to numerous studies, it is clear that both cellular 
EVs and bacterial OMVs are responsible for the etiology of 
periodontal diseases. In contrast, little is known about the 
effects of EVs and OMVs on periodontal medicines, whereas 
the ability of EVs/OMVs seems to be advantageous in 
mechanism by which periodontal disease progresses systemic 
diseases. 
　The further research is warranted to clarify whether and 
how EVs/OMVs contribute to the development of periodontal 
medicine. Especially, the further studies to address the 
following points will be important in understanding of 
periodontal medicine: i) Analysis conducted by in vivo is 
essential. The present data showing relationshp between 
EVs/OMVs and host are mainly provided by in vitro models 
as such as cultured cells or bacteria. Therefore, we should 
confirmed whether EVs/OMVs are actually functional in 
animal models, and whether EVs/OMVs can go to the distant 
organs in mice by using in vivo imaging systems, ii) The 
research field combining mammalian cells and oral bacteria is 
required. To date, the biogenesis and biological roles of EVs 
and OMVs in physical conditions have been well documented, 
respectively. However, little is known about EVs/OMVs 
derived from manmmalian cells infected with periodontal 
bacteria. Because periodontal medicine might be followed by 
periodontal bacterial infection, EVs which are released from 
host cells infected with bacteria is more likely to impact on 
20 Journal of Oral Health and Biosciences　Vol.33, No.1　2020
periodontal medicine.
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